Gibson Energy Inc. (GBNXF)
OTCMKTS · Delayed Price · Currency is USD
18.37
+0.20 (1.10%)
Aug 7, 2025, 11:12 AM EDT
Theseus Pharmaceuticals Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 10,766 | 11,780 | 11,015 | 11,035 | 7,211 | 4,938 | Upgrade | |
Revenue Growth (YoY) | -14.27% | 6.95% | -0.19% | 53.03% | 46.03% | -32.69% | Upgrade |
Cost of Revenue | 10,358 | 11,356 | 10,531 | 10,641 | 6,913 | 4,632 | Upgrade |
Gross Profit | 407.62 | 423.64 | 483.33 | 394.44 | 298.33 | 306.14 | Upgrade |
Selling, General & Admin | 71.99 | 86.88 | 104.06 | 60.98 | 57.87 | 54.5 | Upgrade |
Other Operating Expenses | -7.24 | 1.68 | -0.22 | -10.06 | -6.98 | -6.81 | Upgrade |
Operating Expenses | 64.75 | 88.56 | 103.84 | 60.29 | 61.83 | 59.04 | Upgrade |
Operating Income | 342.88 | 335.08 | 379.49 | 334.15 | 236.5 | 247.1 | Upgrade |
Interest Expense | -135.42 | -139.15 | -115.79 | -65.46 | -61.34 | -64.8 | Upgrade |
Interest & Investment Income | 2.43 | 2.65 | 6.35 | 0.53 | - | 0.22 | Upgrade |
Earnings From Equity Investments | 24.2 | 26.16 | 22.12 | 20.93 | 6.08 | - | Upgrade |
Currency Exchange Gain (Loss) | - | - | -6.84 | - | - | - | Upgrade |
EBT Excluding Unusual Items | 234.08 | 224.74 | 285.33 | 290.14 | 181.24 | 182.51 | Upgrade |
Other Unusual Items | -18.79 | -18.79 | - | - | - | -31.83 | Upgrade |
Pretax Income | 215.29 | 205.95 | 285.33 | 290.14 | 181.24 | 150.68 | Upgrade |
Income Tax Expense | 56.29 | 53.78 | 71.12 | 66.89 | 36.18 | 29.37 | Upgrade |
Earnings From Continuing Operations | 159.01 | 152.17 | 214.21 | 223.25 | 145.05 | 121.31 | Upgrade |
Net Income | 159.01 | 152.17 | 214.21 | 223.25 | 145.05 | 121.31 | Upgrade |
Net Income to Common | 159.01 | 152.17 | 214.21 | 223.25 | 145.05 | 121.31 | Upgrade |
Net Income Growth | -10.55% | -28.96% | -4.05% | 53.91% | 19.57% | -33.67% | Upgrade |
Shares Outstanding (Basic) | 163 | 162 | 150 | 146 | 146 | 146 | Upgrade |
Shares Outstanding (Diluted) | 164 | 164 | 152 | 149 | 149 | 149 | Upgrade |
Shares Change (YoY) | 1.49% | 8.09% | 1.93% | -0.21% | 0.26% | 0.74% | Upgrade |
EPS (Basic) | 0.97 | 0.94 | 1.43 | 1.53 | 0.99 | 0.83 | Upgrade |
EPS (Diluted) | 0.97 | 0.93 | 1.41 | 1.50 | 0.97 | 0.82 | Upgrade |
EPS Growth | -11.00% | -34.04% | -6.00% | 54.64% | 18.29% | -33.57% | Upgrade |
Free Cash Flow | 470.99 | 423.21 | 444.44 | 457.93 | 99.13 | 244.45 | Upgrade |
Free Cash Flow Per Share | 2.86 | 2.58 | 2.93 | 3.08 | 0.67 | 1.64 | Upgrade |
Dividend Per Share | 1.680 | 1.640 | 1.560 | 1.480 | 1.400 | 1.360 | Upgrade |
Dividend Growth | 5.00% | 5.13% | 5.41% | 5.71% | 2.94% | 3.03% | Upgrade |
Gross Margin | 3.79% | 3.60% | 4.39% | 3.57% | 4.14% | 6.20% | Upgrade |
Operating Margin | 3.19% | 2.84% | 3.45% | 3.03% | 3.28% | 5.00% | Upgrade |
Profit Margin | 1.48% | 1.29% | 1.94% | 2.02% | 2.01% | 2.46% | Upgrade |
Free Cash Flow Margin | 4.38% | 3.59% | 4.04% | 4.15% | 1.38% | 4.95% | Upgrade |
EBITDA | 505.77 | 496.05 | 494.33 | 449.44 | 381.24 | 378.56 | Upgrade |
EBITDA Margin | 4.70% | 4.21% | 4.49% | 4.07% | 5.29% | 7.67% | Upgrade |
D&A For EBITDA | 162.9 | 160.97 | 114.84 | 115.3 | 144.74 | 131.46 | Upgrade |
EBIT | 342.88 | 335.08 | 379.49 | 334.15 | 236.5 | 247.1 | Upgrade |
EBIT Margin | 3.19% | 2.84% | 3.45% | 3.03% | 3.28% | 5.00% | Upgrade |
Effective Tax Rate | 26.15% | 26.11% | 24.93% | 23.05% | 19.96% | 19.49% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.